ПРИМЕНЕНИЕ МЕТОДА ЭПР-СПЕКТРОСКОПИИ ДЛЯ ДИАГНОСТИКИ И ПРОГНОЗА ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ

Обложка

Цитировать

Полный текст

Об авторах

Kerstin Schnurr

MedInnovation GmbH

Автор, ответственный за переписку.
Email: k.schnurr@medinnovation.de

Medical Doctor (MD), Head of R&D team Medinnovation GmbH, Berlin, Germany. Groß-Berliner Damm

151б-12487 Berlin; tel.: (+49) 30-720-126-31

Германия

Katja Waterstradt

MedInnovation GmbH

Email: k.waterstradt@medinnovation.de

PhD, Head of laboratory Medinnovation GmbH, Berlin, Germany. Groß-Berliner Damm. 151б-12487, Berlin; tel.: (+49) 30-720-126-31

Германия

Gert Matthes

Institute of Transfusion Medicine

Email: gert.matthes@yahoo.de

Medical doctor (MD), Head of transfusion Department, Institute of Transfusion Medicine, University Hospital Leipzig, Germany

Германия

П. Н. Дмитриев

EPR TECHNOLOGIES LLC

Email: p.dmitriev@medinnovation.de

генеральный директор OOO «ЭПР Технологии»

121552, Москва, Островная ул., д. 2, офис 226; тел.: +7 (495) 234-52-47

Россия

Список литературы

  1. Etzioni R., Urban S., Ramsey M., McIntosh S., Schwartz B., Reid J. et al. The case for early detection. Nat. Rev. Cancer, 2003, Vol. 3, рр. 243–252.
  2. Villanueva D.R., Shaffer J., Philip C.A., Chaparro H., Erdjument-Bromage A.B., Olshen M. et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest. 2006, Vol. 116, рр. 271–284.
  3. Johann D.J.Jr, McGuigan M.D., Patel A.R., Tomov S., Ross S., Conrads T.P. et al. Clinical proteomics and biomarker discovery. Ann. N. Y. Acad. Sci., 2004, Vol. 1022, рр. 295–305.
  4. Liu H., Sadygov R.G., Yates J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem., 2004, Vol. 76, рр. 4193–4201.
  5. Dennis M.S., Zhang M, Meng Y.G., Kadkhodayan D., Kirchofer D., Combs D. et al. Albumin binding as a general strategy for improving pharmacokinetics of proteins. J. Biol. Chem., 2002, Vol. 277, рр. 35035–35043.
  6. Lowenthal M.S., Mehta A.I., Frogale K., Bandle R.W., Araujo R.P., Hood B.L. et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin. Chem., 2005, Vol. 51, рр. 1933–1945.
  7. Mehta A.I., Ross S., Lowenthal M.S., Fusaro V., Fishman D.A., Petricoin E.F. et al. Biomarker amplification by serum carrier protein binding. Dis. Markers., 2003, Vol. 19, рр. 1–10.
  8. Hasan K., Hassan F., Michelis R. The relationship between oxidized serum albumin and blood pressure in hypoalbuminemic peritoneal dialysis patients. Clin. Exp. Hypertens, 2017, Vol. 39(5), рр. 416–420.
  9. Meyer C.P., Rios-Diaz A.J., Dalela D., Ravi P., Sood A., Hanske J., Chun F.K.H., Kibel A.S., Lipsitz S.R., Sun M., Trinh Q.D. The association of hypoalbuminemia with early perioperative outcomes — A comprehensive assessment across 16 major procedures. Am. J. Surg., 2017, Nov., Vol. 214 (5), рр. 871–883.
  10. Oettl K., Stauber R.E. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br. J. Pharmacol., 2007, Vol. 151, рр. 580–590.
  11. Bar-Or D., Winkler J.V., Vanbenthuysen K., Harris L., Lau E., Hetzel F.W. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am. Heart J., 2001, Vol. 141, рр. 985–991.
  12. Apple F.S., Wu A.H., Mair J., Ravkilde J., Panteghini M., Tate J. et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin. Chem., 2005, Vol. 51, рр. 810–824.
  13. Gurachevsky A., Shimanovitch E., Gurachevskaya T., Muravsky V. Intra-albumin migration of bound fatty acid probed by spin label ESR. Biochem. Biophys. Res. Commun., 2007, Vol. 360, рр. 852–856.
  14. Kazmierczak S.C., Gurachevsky A., Matthes G., Muravsky V. Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring. Clin. Chem., 2006, Vol. 52, рр. 2129–2134.
  15. Livshits V.A., Marsh D. Fatty acid binding sites of serum albumin probed by non-linear spin-label EPR. Biochim. Biophys. Acta, 2000, Vol. 1466, рр. 350–360.
  16. Hubbell W.L., Cafiso D.S., Altenbach C. Identifying conformational changes with site-directed spin labeling. Nat. Struct. Biol., 2000, Vol. 7, рр. 735–739.
  17. Curry S., Mandelkow H., Brick P., Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 1998. Vol. 5. Р. 827–835.
  18. Moman R.N., Bhimji S.S. Albumin. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2017, Jun, Vol. 2017, Oct 6.
  19. Peters T. All about albumin: biochemistry, genetics, and medical applications. San Diego, CA: Academic Press, 1996.
  20. Levitt M.H. Spin dynamics: basics of nuclear magnetic resonance. Chichester: John Wiley & Sons, 2001.
  21. Perkins R.C.Jr, Abumrad N., Balasubramanian K., Dalton L.R., Beth A.H., Park J.H. et al. Equilibrium binding of albumin in human blood plasma. Eur. J. Biochem., 1990, Vol. 189, рр. 343–349.
  22. Strancar J. EPRSIM-C: a spectral analysis package. http://www.ijs.si/ijs/dept/epr/EPRSIMC_overview.htm. Accessed March 12, 2008.
  23. Stoll S., Schweiger A. EasySpin, a comprehensive software package for spectral simulation and analysis in EPR. J. Magn. Reson., 2006, Vol. 178, рр. 42–55.
  24. Matthes G., Seibt G., Muravsky V., Hersmann G., Dornheim G. Albumin transport analysis of different collected and processed plasma products by electron spin resonance spectroscopy. Transfus. Apher. Sci., 2002, Vol. 27, рр. 129–135.
  25. Muravskaya E.V., Lapko A.G., Muravskii V.A. Modification of transport function of plasma albumin during atherosclerosis and diabetes mellitus. Bull. Exp. Biol. Med., 2003, Vol. 135, рр. 433–435.
  26. Gurachevsky A., Muravsky V., Matthes G. Changes in serum albumin measured by electron spin resonance: in vitro diagnostic EPR test. Proc. Int. Soc. Magn. Reson. Med., 2007, Vol. 15, рр. 13–23.
  27. Muravsky V., Gurachevsky A., Matthes G. Disease specific albumin patterns defined by electron spin resonance. Tumor Biol., 2007, Vol. 28 (Suppl. 1), р. 19.
  28. Gurachevsky A., Muravskaya E., Gurachevskaya T., Smirnova L., Muravsky V. Cancer-associated alteration in fatty acid binding to albumin studied by spin-label electron spin resonance. Cancer Invest., 2007, Vol. 25, рр. 378–383.
  29. Javrid E., Mashevsky A., Muravsky V., Prokchorova V., Korotkevich E., Milutin A. A comparative study of conformation properties of human serum albumin in lung cancer by spin probe technique. Ann. Oncol., 1994, Vol. 5 (Suppl. 8), р. 9.
  30. Mashevsky A., Muravsky V., Prokchorova V., Milutin A. Comparative investigation of long chain fatty acid binding sites of normal serum albumin with the one from lung cancer patients carried out by the spin probe method. Grizunov J., Dobretsov E., eds. Blood serum albumin in clinical medicine. Moscow: IRUS, 1994.
  31. Glowacki R., Jakubowski H. Cross-talk between Cys34 and lysine residues in human serum albumin revealed by Nhomocysteinylation. J. Biol. Chem., 2004, Vol. 279, рр. 10864–10871.
  32. Gurachevsky A., Kazmierczak S.C., Jorres A., Muravsky V. Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis. Clin. Chem. Lab. Med., 2008, Vol. 46 (9), рр. 1203–1210.
  33. Klammt S., Mitzner S., Stange J., Brinkmann B., Drewelo B., Emmrich J. et al. Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease. Eur. J. Gastroenterol. Hepatol., 2007, Vol. 19, рр. 257–263.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ,


 


Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах